Inotropic Treatment With Levosimendan (SimdaxR)in Heart Surgery

NCT01221116 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

23

Enrollment

OTHER

Sponsor class

Stopped The study was stopped due to difficulties in including patients

Conditions

Heart Failure
Cardiac Surgery

Interventions

DRUG: levosimendan

Sponsor

Ullevaal University Hospital